Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.
- May 28, 2019
Dr. Jaime Grutzendler was inducted into the Connecticut Academy of Science and Engineering
- April 22, 2019
Researchers at the Yale School of Medicine in New Haven, CT are looking for patients with inclusion body myositis (IBM) to participate in a study using Electrical Impedance Myography (EIM). The purpose of the study is to learn if EIM is useful for measuring the severity of inclusion body myositis. If successful, this technique could be used in clinical drug trials, potentially making it easier to gain FDA approval for medications that may benefit IBM patients.
- November 03, 2018
The Society for Neuroscience (SfN) has announced that Stephen G. Waxman, MD, PhD, Bridget M. Flaherty Professor of Neurology and professor of neurobiology and of pharmacology, is this year's recipient of its Julius Axelrod Prize.
- October 25, 2018
Dr. Lauren Sansing, an associate professor at Yale School of Medicine, will receive a prestigious American Neurological Association award later this year. Sansing will be awarded the highest merit offered by the ANA: the Derek Denny-Brown Young Neurological Scholar Award.
- October 17, 2018
David A. Hafler, MD, chair of the Department of Neurology, the William S. and Lois Stiles Edgerly Professor of Neurology, and professor of immunobiology, has been elected to the National Academy of Medicine, in recognition of his outstanding achievements in medicine.
- July 24, 2018
Yale has been approved as a clinical site for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). NeuroNEXT, funded by the National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke (NINDS), is the premier NIH network for neuroscience clinical trials and biomarker studies and aims to streamline Phase II clinical trials for brain disorders.
- May 31, 2018
Better communication between the medical team and families can make a difference.
- May 29, 2018
There is an exciting new development for people with epilepsy whose seizures aren't controlled by drugs or surgery. It's an electronic stimulator that sort of works like a brain defibrillator. CBS2's Dr. Max Gomez reports
- May 28, 2018
The 3rd Critical Care and Emergency Neuroscience CME Course was held on May 24, 2018 at Yale West Campus.
The 3rd Critical Care and Emergency Neuroscience CME Course was held on May 24, 2018 at Yale West Campus. A collaboration between the Departments of Neurology and Neurosurgery, it attracted 180+ registered participants from across the state (and tri-state region). This year’s theme was Resuscitation of Severe and Traumatic Brain Injury (TBI).